Y. Agata, A. Kawasaki, H. Nishimura, Y. Ishida, T. Tsubata et al., Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes, International Immunology, vol.8, issue.5, pp.765-772, 1996.
DOI : 10.1093/intimm/8.5.765

M. J. Ahearne, S. Willimott, L. Pinon, D. B. Kennedy, F. Miall et al., Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia, British Journal of Haematology, vol.207, issue.3, pp.360-370, 2013.
DOI : 10.1111/bjh.12401

S. E. Allan, S. Q. Crome, N. K. Crellin, L. Passerini, T. S. Steiner et al., Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production, International Immunology, vol.19, issue.4, pp.345-354, 2007.
DOI : 10.1093/intimm/dxm014

B. Altvater, S. Landmeier, S. Pscherer, J. Temme, H. Juergens et al., 2B4 (CD244) signaling via chimeric receptors costimulates tumor-antigen specific proliferation and in vitro expansion of human T cells, Cancer Immunology, Immunotherapy, vol.178, issue.12, 1991.
DOI : 10.1007/s00262-009-0704-9

K. M. Ansel, V. N. Ngo, P. L. Hyman, S. A. Luther, R. Forster et al., A chemokine-driven positive feedback loop organizes lymphoid follicles, Nature, vol.406, pp.309-314, 2000.

L. Apetoh, F. Ghiringhelli, A. Tesniere, M. Obeid, C. Ortiz et al., Toll-like receptor 4???dependent contribution of the immune system to anticancer chemotherapy and radiotherapy, Nature Medicine, vol.289, issue.9, pp.1050-1059, 2007.
DOI : 10.1038/nm1622
URL : https://hal.archives-ouvertes.fr/hal-00316924

V. Appay, J. J. Zaunders, L. Papagno, J. Sutton, A. Jaramillo et al., Characterization of CD4+ CTLs Ex Vivo, The Journal of Immunology, vol.168, issue.11, pp.5954-5958, 2002.
DOI : 10.4049/jimmunol.168.11.5954

D. T. Avery, E. K. Deenick, C. S. Ma, S. Suryani, N. Simpson et al., B cell???intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans, The Journal of Experimental Medicine, vol.19, issue.1, pp.155-171, 2010.
DOI : 10.1182/blood-2006-10-054973

M. Awwad and R. J. North, Cyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy-resistant tumour. Evidence that Cy permits the expression of adoptive T-cell mediated immunity by removing suppressor T cells rather than by reducing tumour burden, Immunology, vol.65, pp.87-92, 1988.

L. Aymeric, L. Apetoh, F. Ghiringhelli, A. Tesniere, I. Martins et al., Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity, Cancer Research, vol.70, issue.3, pp.855-858, 2010.
DOI : 10.1158/0008-5472.CAN-09-3566

D. Baatar, P. Olkhanud, K. Sumitomo, D. Taub, R. Gress et al., Human Peripheral Blood T Regulatory Cells (Tregs), Functionally Primed CCR4+ Tregs and Unprimed CCR4- Tregs, Regulate Effector T Cells Using FasL, The Journal of Immunology, vol.178, issue.8, pp.4891-4900, 2007.
DOI : 10.4049/jimmunol.178.8.4891

C. Baecher-allan, J. A. Brown, G. J. Freeman, and D. A. Hafler, CD4+CD25high Regulatory Cells in Human Peripheral Blood, The Journal of Immunology, vol.167, issue.3, pp.1245-1253, 2001.
DOI : 10.4049/jimmunol.167.3.1245

A. Balmanoukian, X. Ye, J. Herman, D. Laheru, and S. A. Grossman, The Association Between Treatment-Related Lymphopenia and Survival in Newly Diagnosed Patients with Resected Adenocarcinoma of the Pancreas, Cancer Investigation, vol.22, issue.8, pp.571-576, 2012.
DOI : 10.1016/j.ijrobp.2004.12.085

G. J. Bates, S. B. Fox, C. Han, R. D. Leek, J. F. Garcia et al., Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse, Journal of Clinical Oncology, vol.24, issue.34, pp.5373-5380, 2006.
DOI : 10.1200/JCO.2006.05.9584

D. Bell, P. Chomarat, D. Broyles, G. Netto, G. M. Harb et al., In Breast Carcinoma Tissue, Immature Dendritic Cells Reside within the Tumor, whereas Mature Dendritic Cells Are Located in Peritumoral Areas, Journal of Experimental Medicine, vol.190, issue.10, pp.1417-1426, 1999.
DOI : 10.1084/jem.190.10.1417

C. L. Bennett, J. Christie, F. Ramsdell, M. E. Brunkow, P. J. Ferguson et al., The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3, Nat Genet, vol.27, pp.20-21, 2001.

M. Beyer, M. Kochanek, K. Darabi, A. Popov, M. Jensen et al., Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine, Blood, vol.106, issue.6, pp.2018-2025, 2005.
DOI : 10.1182/blood-2005-02-0642

F. Bihl, J. Pecheur, B. Breart, G. Poupon, J. Cazareth et al., Primed Antigen-Specific CD4+ T Cells Are Required for NK Cell Activation In Vivo upon Leishmania major Infection, The Journal of Immunology, vol.185, issue.4, pp.2174-2181, 2010.
DOI : 10.4049/jimmunol.1001486
URL : https://hal.archives-ouvertes.fr/hal-00724243

P. Billings, S. Burakoff, M. E. Dorf, and B. Benacerraf, Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products, Journal of Experimental Medicine, vol.145, issue.5, pp.1387-1392, 1977.
DOI : 10.1084/jem.145.5.1387

M. E. Birnbaum, S. Dong, and K. C. Garcia, Diversity-oriented approaches for interrogating T-cell receptor repertoire, ligand recognition, and function, Immunological Reviews, vol.108, issue.1, pp.82-101, 2012.
DOI : 10.1111/imr.12006

N. J. Booth, A. J. Mcquaid, T. Sobande, S. Kissane, E. Agius et al., Different Proliferative Potential and Migratory Characteristics of Human CD4+ Regulatory T Cells That Express either CD45RA or CD45RO, The Journal of Immunology, vol.184, issue.8, pp.4317-4326, 2010.
DOI : 10.4049/jimmunol.0903781

C. Boshoff and R. Weiss, Aids-related malignancies, Nature Reviews Cancer, vol.2, issue.5, pp.373-382, 2002.
DOI : 10.1038/nrc797

H. Bour-jordan, J. H. Esensten, M. Martinez-llordella, C. Penaranda, M. Stumpf et al., Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/???B7 family, Immunological Reviews, vol.355, issue.Suppl., pp.180-205, 2011.
DOI : 10.1111/j.1600-065X.2011.01011.x

C. Bourgeois, B. Rocha, and C. Tanchot, A Role for CD40 Expression on CD8+ T Cells in the Generation of CD8+ T Cell Memory, Science, vol.297, issue.5589, pp.2060-2063, 2002.
DOI : 10.1126/science.1072615

J. R. Brahmer, S. S. Tykodi, L. Q. Chow, W. J. Hwu, S. L. Topalian et al., Safety and Activity of Anti???PD-L1 Antibody in Patients with Advanced Cancer, New England Journal of Medicine, vol.366, issue.26, pp.2455-2465, 2012.
DOI : 10.1056/NEJMoa1200694

G. Brown, M. Malakouti, E. Wang, J. Y. Koo, L. et al., Anti-IL-17 phase II data for psoriasis: A review, Journal of Dermatological Treatment, vol.27, issue.1, 2014.
DOI : 10.1007/s12016-012-8307-1

F. M. Burnet, The Concept of Immunological Surveillance, Prog Exp Tumor Res, vol.13, pp.1-27, 1970.
DOI : 10.1159/000386035

J. L. Cannons, H. Qi, K. T. Lu, M. Dutta, J. Gomez-rodriguez et al., Optimal Germinal Center Responses Require??a Multistage T Cell:B Cell Adhesion Process Involving Integrins, SLAM-Associated Protein, and CD84, Immunity, vol.32, issue.2, pp.253-265, 2010.
DOI : 10.1016/j.immuni.2010.01.010

J. Carrasco, A. Van-pel, B. Neyns, B. Lethe, F. Brasseur et al., Vaccination of a Melanoma Patient with Mature Dendritic Cells Pulsed with MAGE-3 Peptides Triggers the Activity of Nonvaccine Anti-Tumor Cells, The Journal of Immunology, vol.180, issue.5, pp.3585-3593, 2008.
DOI : 10.4049/jimmunol.180.5.3585

J. P. Casazza, M. R. Betts, D. A. Price, M. L. Precopio, L. E. Ruff et al., T lymphocytes with cellular maturation, The Journal of Experimental Medicine, vol.151, issue.13, pp.2865-2877, 2006.
DOI : 10.1016/S0145-305X(02)00039-3

S. Chaganti, C. S. Ma, A. I. Bell, D. Croom-carter, A. D. Hislop et al., Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+CD27+ B cells harbor the virus in X-linked lymphoproliferative disease patients, Blood, vol.112, issue.3, pp.672-679, 2008.
DOI : 10.1182/blood-2007-10-116269

J. R. Chapman, A. C. Webster, and G. Wong, Cancer in the Transplant Recipient, Cold Spring Harbor Perspectives in Medicine, vol.3, issue.7, 2013.
DOI : 10.1101/cshperspect.a015677

P. K. Chattopadhyay, J. Yu, and M. Roederer, Live-cell assay to detect antigen-specific CD4+ T-cell responses by CD154 expression, Nature Protocols, vol.172, issue.1, pp.1-6, 2006.
DOI : 10.1038/nprot.2006.1

G. Chen and L. A. Emens, Chemoimmunotherapy: reengineering tumor immunity. Cancer immunology, immunotherapy : CII 62, pp.203-216, 2013.
DOI : 10.1007/s00262-012-1388-0
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608094

X. Chen, J. Wan, J. Liu, W. Xie, X. Diao et al., Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients, Lung Cancer, vol.69, issue.3, pp.348-354, 2010.
DOI : 10.1016/j.lungcan.2009.11.013

Y. S. Choi, R. Kageyama, D. Eto, T. C. Escobar, R. J. Johnston et al., ICOS Receptor Instructs T Follicular Helper Cell versus Effector Cell Differentiation via Induction of the Transcriptional Repressor Bcl6, Immunity, vol.34, issue.6, pp.932-946, 2011.
DOI : 10.1016/j.immuni.2011.03.023

Y. Chung, S. Tanaka, F. Chu, R. I. Nurieva, G. J. Martinez et al., Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions, Nature Medicine, vol.176, issue.8, pp.983-988, 2011.
DOI : 10.1038/ng0697-161
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151340

W. H. Clark, . Jr, D. E. Elder, D. T. Guerry, L. E. Braitman et al., Model Predicting Survival in Stage I Melanoma Based on Tumor Progression, JNCI Journal of the National Cancer Institute, vol.81, issue.24, pp.1893-1904, 1989.
DOI : 10.1093/jnci/81.24.1893

P. Correale, A. Aquino, A. Giuliani, M. Pellegrini, L. Micheli et al., Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cellsin vitro, International Journal of Cancer, vol.269, issue.4, 2003.
DOI : 10.1002/ijc.10969

L. Cosmi, R. De-palma, V. Santarlasci, L. Maggi, M. Capone et al., T cell precursor, The Journal of Experimental Medicine, vol.94, issue.8, pp.1903-1916, 2008.
DOI : 10.1182/blood-2004-04-1667

P. G. Coulie, M. Somville, F. Lehmann, P. Hainaut, F. Brasseur et al., Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells, International Journal of Cancer, vol.67, issue.2, pp.289-297, 1992.
DOI : 10.1002/ijc.2910500220

F. Crawford, K. R. Jordan, B. Stadinski, Y. Wang, E. Huseby et al., Use of baculovirus MHC/peptide display libraries to characterize T-cell receptor ligands, Immunological Reviews, vol.88, issue.1, pp.156-170, 2006.
DOI : 10.1016/0092-8674(89)90844-1

F. Cruz-guilloty, M. E. Pipkin, I. M. Djuretic, D. Levanon, J. Lotem et al., Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs, The Journal of Experimental Medicine, vol.206, issue.1, pp.51-59, 2009.
DOI : 10.1093/nar/gkl006

T. J. Curiel, G. Coukos, L. Zou, X. Alvarez, P. Cheng et al., Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival, Nature Medicine, vol.165, issue.9, pp.942-949, 2004.
DOI : 10.1016/S0022-1759(01)00359-3

M. A. Curran, T. L. Geiger, W. Montalvo, M. Kim, S. L. Reiner et al., Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin, The Journal of Experimental Medicine, vol.163, issue.4, pp.743-755, 2013.
DOI : 10.4049/jimmunol.0901199

G. Darrasse-jeze, A. S. Bergot, A. Durgeau, F. Billiard, B. L. Salomon et al., Tumor emergence is sensed by selfspecific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice, The Journal of clinical investigation, vol.119, pp.2648-2662, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00420216

C. L. Day, D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley et al., PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression, Nature, vol.170, issue.7109, pp.350-354, 2006.
DOI : 10.1126/science.274.5284.94

L. De-chaisemartin, J. Goc, D. Damotte, P. Validire, P. Magdeleinat et al., Characterization of Chemokines and Adhesion Molecules Associated with T cell Presence in Tertiary Lymphoid Structures in Human Lung Cancer, Cancer Research, vol.71, issue.20, pp.6391-6399, 2011.
DOI : 10.1158/0008-5472.CAN-11-0952

L. De-leval, C. Gisselbrecht, and P. Gaulard, Advances in the understanding and management of angioimmunoblastic T-cell lymphoma, British Journal of Haematology, vol.9, issue.Suppl. 2, pp.673-689, 2010.
DOI : 10.1111/j.1365-2141.2009.08003.x

L. De-leval, D. S. Rickman, C. Thielen, A. Reynies, Y. L. Huang et al., The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells, Blood, vol.109, issue.11, pp.4952-4963, 2007.
DOI : 10.1182/blood-2006-10-055145

J. Degregori, Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?, Oncogene, vol.114, issue.15, pp.1869-1875, 2013.
DOI : 10.1038/onc.2012.281

R. J. Deleeuw, S. E. Kost, J. A. Kakal, N. , and B. H. , The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature. Clinical cancer research : an official journal of the, pp.3022-3029, 2012.

D. G. Denardo, D. J. Brennan, E. Rexhepaj, B. Ruffell, S. L. Shiao et al., Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy, Cancer Discovery, vol.1, issue.1, pp.54-67, 2011.
DOI : 10.1158/2159-8274.CD-10-0028

C. Denkert, S. Loibl, A. Noske, M. Roller, B. M. Muller et al., Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer, Journal of Clinical Oncology, vol.28, issue.1, pp.105-113, 2010.
DOI : 10.1200/JCO.2009.23.7370

D. Mitri, D. Azevedo, R. I. Henson, S. M. Libri, V. Riddell et al., Reversible Senescence in Human CD4+CD45RA+CD27- Memory T Cells, The Journal of Immunology, vol.187, issue.5, pp.2093-2100, 2011.
DOI : 10.4049/jimmunol.1100978

M. V. Dieci, C. Criscitiello, A. Goubar, G. Viale, P. Conte et al., Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study, Annals of Oncology, vol.25, issue.3, pp.611-618, 2014.
DOI : 10.1093/annonc/mdt556

M. E. Dudley, J. R. Wunderlich, J. C. Yang, P. Hwu, D. J. Schwartzentruber et al., A Phase I Study of Nonmyeloablative Chemotherapy and Adoptive Transfer of Autologous Tumor Antigen-Specific T Lymphocytes in Patients With Metastatic Melanoma, Journal of Immunotherapy, vol.25, issue.3, pp.243-251, 2002.
DOI : 10.1097/00002371-200205000-00007

M. E. Dudley, J. C. Yang, R. Sherry, M. S. Hughes, R. Royal et al., Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens, Journal of Clinical Oncology, vol.26, issue.32, pp.5233-5239, 2008.
DOI : 10.1200/JCO.2008.16.5449

R. M. Dunham, B. Cervasi, J. M. Brenchley, H. Albrecht, A. Weintrob et al., CD127 and CD25 Expression Defines CD4+ T Cell Subsets That Are Differentially Depleted during HIV Infection, The Journal of Immunology, vol.180, issue.8, pp.5582-5592, 2008.
DOI : 10.4049/jimmunol.180.8.5582
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683429

G. P. Dunn, A. T. Bruce, H. Ikeda, L. J. Old, and R. D. Schreiber, Cancer immunoediting: from immunosurveillance to tumor escape, Nature Immunology, vol.3, issue.11, pp.991-998, 2002.
DOI : 10.1038/ni1102-991

E. Elkord, S. Sharma, D. J. Burt, and R. E. Hawkins, Expanded subpopulation of FoxP3+ T regulatory cells in renal cell carcinoma co-express Helios, indicating they could be derived from natural but not induced Tregs, Clinical Immunology, vol.140, issue.3, pp.218-222, 2011.
DOI : 10.1016/j.clim.2011.04.014

M. R. Elliott, F. B. Chekeni, P. C. Trampont, E. R. Lazarowski, A. Kadl et al., Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance, Nature, vol.127, issue.7261, pp.282-286, 2009.
DOI : 10.1038/nature08296

R. O. Emerson, A. M. Sherwood, M. J. Rieder, J. Guenthoer, D. W. Williamson et al., High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer, The Journal of Pathology, vol.39, issue.Suppl 1, pp.433-440, 2013.
DOI : 10.1002/path.4260

A. Facciabene, X. Peng, I. S. Hagemann, K. Balint, A. Barchetti et al., Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells, Nature, vol.31, issue.7355, pp.226-230, 2011.
DOI : 10.1038/nature10169

J. Faget, C. Biota, T. Bachelot, M. Gobert, I. Treilleux et al., Early Detection of Tumor Cells by Innate Immune Cells Leads to Treg Recruitment through CCL22 Production by Tumor Cells, Cancer Research, vol.71, issue.19, pp.6143-6152, 2011.
DOI : 10.1158/0008-5472.CAN-11-0573
URL : https://hal.archives-ouvertes.fr/hal-00811875

J. D. Fontenot, M. A. Gavin, and A. Y. Rudensky, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells, Nature Immunology, vol.4, issue.4, pp.330-336, 2003.
DOI : 10.1038/ni904

J. D. Fontenot, J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky, A function for interleukin 2 in Foxp3-expressing regulatory T cells, Nature Immunology, vol.171, issue.11, pp.1142-1151, 2005.
DOI : 10.1186/gb-2004-5-10-r80

T. M. Foy, J. D. Laman, J. A. Ledbetter, A. Aruffo, E. Claassen et al., gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory, Journal of Experimental Medicine, vol.180, issue.1, pp.157-163, 1994.
DOI : 10.1084/jem.180.1.157

L. M. Francisco, V. H. Salinas, K. E. Brown, V. K. Vanguri, G. J. Freeman et al., PD-L1 regulates the development, maintenance, and function of induced regulatory T cells, The Journal of Experimental Medicine, vol.63, issue.13, pp.3015-3029, 2009.
DOI : 10.1016/j.molimm.2007.08.013

D. M. Frey, R. A. Droeser, C. T. Viehl, I. Zlobec, A. Lugli et al., regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients, International Journal of Cancer, vol.68, pp.2635-2643, 2010.
DOI : 10.1002/ijc.24989

W. H. Fridman, F. Pages, C. Sautes-fridman, and J. Galon, The immune contexture in human tumours: impact on clinical outcome, Nature Reviews Cancer, vol.29, issue.4, pp.298-306, 2012.
DOI : 10.1038/nrc3245

J. Fucikova, P. Kralikova, A. Fialova, T. Brtnicky, L. Rob et al., Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response, Cancer Research, vol.71, issue.14, pp.4821-4833, 2011.
DOI : 10.1158/0008-5472.CAN-11-0950

S. Fujino, A. Andoh, S. Bamba, A. Ogawa, K. Hata et al., Increased expression of interleukin 17 in inflammatory bowel disease, Gut, vol.52, issue.1, pp.65-70, 2003.
DOI : 10.1136/gut.52.1.65

J. Galon, A. Costes, F. Sanchez-cabo, A. Kirilovsky, B. Mlecnik et al., Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome, Science, vol.313, issue.5795, pp.1960-1964, 2006.
DOI : 10.1126/science.1129139

H. Ghebeh, C. Lehe, E. Barhoush, K. Al-romaih, A. Tulbah et al., Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule, Breast Cancer Research, vol.266, issue.4, p.48, 2010.
DOI : 10.1001/jama.1991.03470120074036

F. Ghiringhelli, L. Apetoh, A. Tesniere, L. Aymeric, Y. Ma et al., Activation of the NLRP3 inflammasome in dendritic cells induces IL-1?????dependent adaptive immunity against tumors, Nature Medicine, vol.7, issue.10, pp.1170-1178, 2009.
DOI : 10.1038/nm.2028
URL : https://hal.archives-ouvertes.fr/hal-00419823

F. Ghiringhelli, C. Menard, P. E. Puig, S. Ladoire, S. Roux et al., Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients, Cancer Immunology, Immunotherapy, vol.95, issue.5, pp.641-648, 2007.
DOI : 10.1007/s00262-006-0225-8

M. Gobert, I. Treilleux, N. Bendriss-vermare, T. Bachelot, S. Goddard-leon et al., Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome, Cancer Research, vol.69, issue.5, 2000.
DOI : 10.1158/0008-5472.CAN-08-2360

E. Godefroy, Y. Wang, N. E. Souleimanian, L. Scotto, S. Stevanovic et al., Assessment of CD4+?? T cells specific for the tumor antigen SSX-1 in cancer-free individuals, Cancer Immunology, Immunotherapy, vol.117, issue.8, pp.1183-1192, 2007.
DOI : 10.1007/s00262-006-0269-9

S. R. Goding, K. A. Wilson, Y. Xie, K. M. Harris, A. Baxi et al., Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma, The Journal of Immunology, vol.190, issue.9, pp.4899-4909, 2013.
DOI : 10.4049/jimmunol.1300271

A. W. Goldrath, L. Y. Bogatzki, and M. J. Bevan, Naive T Cells Transiently Acquire a Memory-like Phenotype during Homeostasis-Driven Proliferation, The Journal of Experimental Medicine, vol.161, issue.4, pp.557-564, 2000.
DOI : 10.1016/S1074-7613(00)80564-6

A. W. Goldrath, P. V. Sivakumar, M. Glaccum, M. K. Kennedy, M. J. Bevan et al., T Cells, The Journal of Experimental Medicine, vol.157, issue.12, pp.1515-1522, 2002.
DOI : 10.1084/jem.192.5.659

J. Gotot, C. Gottschalk, S. Leopold, P. A. Knolle, H. Yagita et al., Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo, Proceedings of the National Academy of Sciences of the United States of America, pp.10468-10473, 2012.
DOI : 10.1073/pnas.1201131109

C. Gu-trantien, S. Loi, S. Garaud, C. Equeter, M. Libin et al., CD4+ follicular helper T cell infiltration predicts breast cancer survival, Journal of Clinical Investigation, vol.123, issue.7, pp.2873-2892, 2013.
DOI : 10.1172/JCI67428DS1

A. Hamai, P. Pignon, I. Raimbaud, K. Duperrier-amouriaux, H. Senellart et al., Human TH17 Immune Cells Specific for the Tumor Antigen MAGE-A3 Convert to IFN-??-Secreting Cells as They Differentiate into Effector T Cells In Vivo, Cancer Research, vol.72, issue.5, pp.1059-1063, 2012.
DOI : 10.1158/0008-5472.CAN-11-3432

E. Hams, M. J. Mccarron, S. Amu, H. Yagita, M. Azuma et al., Blockade of B7-H1 (Programmed Death Ligand 1) Enhances Humoral Immunity by Positively Regulating the Generation of T Follicular Helper Cells, The Journal of Immunology, vol.186, issue.10, pp.5648-5655, 2011.
DOI : 10.4049/jimmunol.1003161

D. Hanahan and R. A. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2011.
DOI : 10.1016/j.cell.2011.02.013

L. E. Harrington, R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy et al., Interleukin 17???producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages, Nature Immunology, vol.173, issue.11, pp.1123-1132, 2005.
DOI : 10.1016/S1074-7613(00)80470-7

L. J. Hatam, J. A. Devoti, D. W. Rosenthal, F. Lam, A. L. Abramson et al., Immune Suppression in Premalignant Respiratory Papillomas: Enriched Functional CD4+Foxp3+ Regulatory T Cells and PD-1/PD-L1/L2 Expression, Clinical cancer research : an official journal of the American Association for Cancer Research, pp.1925-1935, 2012.
DOI : 10.1158/1078-0432.CCR-11-2941

M. Avogadri-connors, F. Yuan, J. Li, and Y. , Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype, The Journal of experimental medicine, vol.209, pp.2113-2126, 2012.

F. S. Hodi, S. J. O-'day, D. F. Mcdermott, R. W. Weber, J. A. Sosman et al., Improved Survival with Ipilimumab in Patients with Metastatic Melanoma, New England Journal of Medicine, vol.363, issue.8, pp.711-723, 2010.
DOI : 10.1056/NEJMoa1003466

S. Hori, T. Nomura, and S. Sakaguchi, Control of Regulatory T Cell Development by the Transcription Factor Foxp3, Science, vol.299, issue.5609, pp.1057-1061, 2003.
DOI : 10.1126/science.1079490

N. N. Hunder, H. Wallen, J. Cao, D. W. Hendricks, J. Z. Reilly et al., Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1, New England Journal of Medicine, vol.358, issue.25, pp.2698-2703, 2008.
DOI : 10.1056/NEJMoa0800251

C. Infante-duarte, H. F. Horton, M. C. Byrne, and T. Kamradt, Microbial Lipopeptides Induce the Production of IL-17 in Th Cells, The Journal of Immunology, vol.165, issue.11, pp.6107-6115, 2000.
DOI : 10.4049/jimmunol.165.11.6107

T. Ishida, T. Joh, N. Uike, K. Yamamoto, A. Utsunomiya et al., Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study, Journal of Clinical Oncology, vol.30, issue.8, pp.837-842, 2012.
DOI : 10.1200/JCO.2011.37.3472

Y. Ishida, Y. Agata, K. Shibahara, and T. Honjo, Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death, EMBO J, vol.11, pp.3887-3895, 1992.

I. Ivanov, B. S. Mckenzie, L. Zhou, C. E. Tadokoro, A. Lepelley et al., The Orphan Nuclear Receptor ROR??t Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells, Cell, vol.126, issue.6, pp.1121-1133, 2006.
DOI : 10.1016/j.cell.2006.07.035

S. Jacobson, J. R. Richert, W. E. Biddison, A. Satinsky, R. J. Hartzman et al., Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens, Journal of immunology, vol.133, pp.754-757, 1984.

C. H. June, Adoptive T cell therapy for cancer in the clinic, Journal of Clinical Investigation, vol.117, issue.6, pp.1466-1476, 2007.
DOI : 10.1172/JCI32446

D. H. Kaplan, V. Shankaran, A. S. Dighe, E. Stockert, M. Aguet et al., Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice, Proceedings of the National Academy of Sciences of the United States of America 95, pp.7556-7561, 1998.

J. Kappler, J. White, H. Kozono, J. Clements, and P. Marrack, Binding of a soluble alpha beta T-cell receptor to superantigen/major histocompatibility complex ligands., Proceedings of the National Academy of Sciences of the United States of America 91, pp.8462-8466, 1994.
DOI : 10.1073/pnas.91.18.8462

J. A. Keene and J. Forman, Helper activity is required for the in vivo generation of cytotoxic T lymphocytes, Journal of Experimental Medicine, vol.155, issue.3, pp.768-782, 1982.
DOI : 10.1084/jem.155.3.768

B. W. Kirkham, M. N. Lassere, J. P. Edmonds, K. M. Juhasz, P. A. Bird et al., Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: A two-year prospective study (the DAMAGE study cohort), Arthritis & Rheumatism, vol.50, issue.4, pp.1122-1131, 2006.
DOI : 10.1002/art.21749

U. Klein, Y. Tu, G. A. Stolovitzky, J. L. Keller, J. Haddad et al., Transcriptional analysis of the B cell germinal center reaction, Proceedings of the National Academy of Sciences of the United States of America, pp.2639-2644, 2003.
DOI : 10.1073/pnas.0437996100

P. Klucar, P. F. Barnes, Y. Kong, B. Samten, A. Tvinnereim et al., Characterization of effector functions of human peptide-specific CD4+ T-cell clones for an intracellular pathogen, Human Immunology, vol.69, issue.8, pp.475-483, 2008.
DOI : 10.1016/j.humimm.2008.05.008

C. A. Knosp and J. A. Johnston, Regulation of CD4+ T-cell polarization by suppressor of cytokine signalling proteins, Immunology, vol.281, issue.2, pp.101-111, 2012.
DOI : 10.1111/j.1365-2567.2011.03520.x

K. N. Kodumudi, K. Woan, D. L. Gilvary, E. Sahakian, S. Wei et al., A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers. Clinical cancer research : an official journal of the American Association for, Cancer Research, vol.16, pp.4583-4594, 2010.

C. M. Koebel, W. Vermi, J. B. Swann, N. Zerafa, S. J. Rodig et al., Adaptive immunity maintains occult cancer in an equilibrium state, Nature, vol.410, issue.7171, pp.903-907, 2007.
DOI : 10.1038/nature06309

L. Krenacs, P. Schaerli, G. Kis, and E. Bagdi, Phenotype of neoplastic cells in angioimmunoblastic T-cell lymphoma is consistent with activated follicular B helper T cells, Blood, vol.108, issue.3, pp.1110-1111, 2006.
DOI : 10.1182/blood-2006-01-0394

A. S. Krupnick, A. E. Gelman, W. Barchet, S. Richardson, F. H. Kreisel et al., Cutting Edge: Murine Vascular Endothelium Activates and Induces the Generation of Allogeneic CD4+25+Foxp3+ Regulatory T Cells, The Journal of Immunology, vol.175, issue.10, pp.6265-6270, 2005.
DOI : 10.4049/jimmunol.175.10.6265

I. Kryczek, M. Banerjee, P. Cheng, L. Vatan, W. Szeliga et al., Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments, Blood, vol.114, issue.6, pp.1141-1149, 2009.
DOI : 10.1182/blood-2009-03-208249

I. Kryczek, A. T. Bruce, J. E. Gudjonsson, A. Johnston, A. Aphale et al., Induction of IL-17+ T Cell Trafficking and Development by IFN-??: Mechanism and Pathological Relevance in Psoriasis, The Journal of Immunology, vol.181, issue.7, pp.4733-4741, 2008.
DOI : 10.4049/jimmunol.181.7.4733

I. Kryczek, A. Lange, P. Mottram, X. Alvarez, P. Cheng et al., CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers, Cancer research, vol.65, pp.465-472, 2005.

I. Kryczek, S. Wei, G. Zhu, L. Myers, P. Mottram et al., Relationship between B7-H4, Regulatory T Cells, and Patient Outcome in Human Ovarian Carcinoma, Cancer Research, vol.67, issue.18, pp.8900-8905, 2007.
DOI : 10.1158/0008-5472.CAN-07-1866

I. Kryczek, S. Wei, L. Zou, S. Altuwaijri, W. Szeliga et al., Cutting Edge: Th17 and Regulatory T Cell Dynamics and the Regulation by IL-2 in the Tumor Microenvironment, The Journal of Immunology, vol.178, issue.11, pp.6730-6733, 2007.
DOI : 10.4049/jimmunol.178.11.6730

A. Ladanyi, J. Kiss, A. Mohos, B. Somlai, G. Liszkay et al., Prognostic impact of B-cell density in cutaneous melanoma, Cancer Immunology, Immunotherapy, vol.4, issue.12, pp.1729-1738, 2011.
DOI : 10.1007/s00262-011-1071-x

S. Ladoire, L. Arnould, L. Apetoh, B. Coudert, F. Martin et al., Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells. Clinical cancer research : an official journal of the American Association for, Cancer Research, vol.14, pp.2413-2420, 2008.

S. Ladoire, F. Martin, and F. Ghiringhelli, Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer immunology, immunotherapy : CII 60, pp.909-918, 2011.

S. Ladoire, G. Mignot, S. Dabakuyo, L. Arnould, L. Apetoh et al., In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival, The Journal of Pathology, vol.5, issue.3, pp.389-400, 2011.
DOI : 10.1002/path.2866

C. L. Langrish, Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation, The Journal of Experimental Medicine, vol.71, issue.2, pp.233-240, 2005.
DOI : 10.1038/nri802

V. Libri, R. I. Azevedo, S. E. Jackson, D. Mitri, D. Lachmann et al., Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+???CD45RA+???CD27??? T cells: the potential involvement of interleukin-7 in this process, Immunology, vol.30, issue.3, pp.326-339, 2011.
DOI : 10.1111/j.1365-2567.2010.03386.x

W. Lin, D. Haribhai, L. M. Relland, N. Truong, M. R. Carlson et al., Regulatory T cell development in the absence of functional Foxp3, Nature Immunology, vol.174, issue.4, pp.359-368, 2007.
DOI : 10.1186/gb-2004-5-10-r80

Y. C. Lin, L. Y. Chang, C. T. Huang, H. M. Peng, A. Dutta et al., Effector/Memory but Not Naive Regulatory T Cells Are Responsible for the Loss of Concomitant Tumor Immunity, The Journal of Immunology, vol.182, issue.10, pp.6095-6104, 2009.
DOI : 10.4049/jimmunol.0803829

C. Linnemann, R. Mezzadra, and T. N. Schumacher, TCR repertoires of intratumoral T-cell subsets, Immunological Reviews, vol.10, issue.1, pp.72-82, 2014.
DOI : 10.1111/imr.12140

J. Liu, Y. Duan, X. Cheng, X. Chen, W. Xie et al., IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma, Biochemical and Biophysical Research Communications, vol.407, issue.2, pp.348-354, 2011.
DOI : 10.1016/j.bbrc.2011.03.021

M. Lohr, K. Edlund, J. Botling, S. Hammad, B. Hellwig et al., The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer, Cancer Letters, vol.333, issue.2, pp.222-228, 2013.
DOI : 10.1016/j.canlet.2013.01.036

E. Lubberts, IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis?, Cytokine, vol.41, issue.2, pp.84-91, 2008.
DOI : 10.1016/j.cyto.2007.09.014

C. S. Ma, N. J. Hare, K. E. Nichols, L. Dupre, G. Andolfi et al., Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells, Journal of Clinical Investigation, vol.115, issue.4, pp.1049-1059, 2005.
DOI : 10.1172/JCI200523139

C. S. Ma, S. Pittaluga, D. T. Avery, N. J. Hare, I. Maric et al., Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease, Journal of Clinical Investigation, vol.116, issue.2, pp.322-333, 2006.
DOI : 10.1172/JCI25720

A. Mackensen, L. Ferradini, G. Carcelain, F. Triebel, F. Faure et al., Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma, Cancer research, vol.53, pp.3569-3573, 1993.

S. Manici, T. Sturniolo, M. A. Imro, J. Hammer, F. Sinigaglia et al., Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11, The Journal of Experimental Medicine, vol.154, issue.5, pp.871-876, 1999.
DOI : 10.1002/(SICI)1097-0215(19980130)75:3<384::AID-IJC10>3.0.CO;2-9

A. Mantovani and M. Locati, Orchestration of macrophage polarization, Blood, vol.114, issue.15, pp.3135-3136, 2009.
DOI : 10.1182/blood-2009-07-231795

M. Martinez-llordella, J. H. Esensten, S. L. Bailey-bucktrout, R. H. Lipsky, A. Marini et al., T cell response, The Journal of Experimental Medicine, vol.2012, issue.8, pp.1603-1619, 2013.
DOI : 10.1089/omi.2009.0014

G. Martins, C. , and K. , Regulation and Functions of Blimp-1 in T and B Lymphocytes, Annual Review of Immunology, vol.26, issue.1, pp.133-169, 2008.
DOI : 10.1146/annurev.immunol.26.021607.090241

J. Marturano, R. Longhi, V. Russo, and M. P. Protti, Endosomal Proteases Influence the Repertoire of MAGE-A3 Epitopes Recognized In vivo by CD4+ T Cells, Cancer Research, vol.68, issue.5, pp.1555-1562, 2008.
DOI : 10.1158/0008-5472.CAN-07-5233

T. Maruyama, K. Kono, S. Izawa, Y. Mizukami, Y. Kawaguchi et al., CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma, Diseases of the Esophagus, vol.23, pp.422-429, 2010.
DOI : 10.1111/j.1442-2050.2009.01029.x

T. Maruyama, K. Kono, Y. Mizukami, Y. Kawaguchi, K. Mimura et al., Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer, Cancer Science, vol.13, issue.9, pp.1947-1954, 2010.
DOI : 10.1111/j.1349-7006.2010.01624.x

R. Mazzucchelli and S. K. Durum, Interleukin-7 receptor expression: intelligent design, Nature Reviews Immunology, vol.18, issue.2, pp.144-154, 2007.
DOI : 10.1038/nri2023

B. Melichar, M. Touskova, J. Dvorak, P. Jandik, and O. Kopecky, THE PERIPHERAL BLOOD LEUKOCYTE PHENOTYPE IN PATIENTS WITH BREAST CANCER: EFFECT OF DOXORUBICIN/PACLITAXEL COMBINATION CHEMOTHERAPY, Immunopharmacology and Immunotoxicology, vol.14, issue.2, pp.163-173, 2001.
DOI : 10.1007/BF00682702

H. J. Meyerson, A. Awadallah, P. Pavlidakey, K. Cooper, K. Honda et al., Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome, Modern Pathology, vol.1, issue.1, pp.32-43, 2013.
DOI : 10.1182/blood-2010-05-287664

B. Min, H. Yamane, J. Hu-li, P. , and W. E. , Spontaneous and Homeostatic Proliferation of CD4 T Cells Are Regulated by Different Mechanisms, The Journal of Immunology, vol.174, issue.10, pp.6039-6044, 2005.
DOI : 10.4049/jimmunol.174.10.6039

I. Mishalian, R. Bayuh, E. Eruslanov, J. Michaeli, L. Levy et al., Neutrophils recruit regulatory Tcells into tumors via secretion of CCL17-A new mechanism of impaired antitumor immunity, Z. G. Int J Cancer, 2014.

N. A. Mitchison, The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation, European Journal of Immunology, vol.227, issue.1, pp.18-27, 1971.
DOI : 10.1002/eji.1830010104

M. Miyara, Y. Yoshioka, A. Kitoh, T. Shima, K. Wing et al., Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor, Immunity, vol.30, issue.6, pp.899-911, 2009.
DOI : 10.1016/j.immuni.2009.03.019

K. Miyazaki, M. Miyazaki, Y. Guo, N. Yamasaki, M. Kanno et al., The Role of the Basic Helix-Loop-Helix Transcription Factor Dec1 in the Regulatory T Cells, The Journal of Immunology, vol.185, issue.12, pp.7330-7339, 2010.
DOI : 10.4049/jimmunol.1001381

Y. Mizukami, K. Kono, Y. Kawaguchi, H. Akaike, K. Kamimura et al., CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer, International Journal of Cancer, vol.31, issue.10, pp.2286-2293, 2008.
DOI : 10.1002/ijc.23392

Y. Morishita, P. J. Martin, M. A. Bean, H. Yamada, and J. A. Hansen, Antigenspecific functions of a CD4+ subset of human T lymphocytes with granular morphology, Journal of immunology, vol.136, pp.2095-2102, 1986.

Y. Morishita, H. Sao, J. A. Hansen, M. , and P. J. , A distinct subset of human CD4+ cells with a limited alloreactive T cell receptor repertoire, Journal of immunology, vol.143, pp.2783-2789, 1989.

M. Morre and S. Beq, Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival, Targeted Oncology, vol.21, issue.10, pp.55-68, 2012.
DOI : 10.1007/s11523-012-0210-4

D. Mucida, M. M. Husain, S. Muroi, F. Van-wijk, R. Shinnakasu et al., Transcriptional reprogramming of mature CD4+ helper T cells generates distinct MHC class II???restricted cytotoxic T lymphocytes, Nature Immunology, vol.158, issue.3, pp.281-289, 2013.
DOI : 10.1016/S0022-1759(03)00265-5

D. Muller, B. H. Koller, J. L. Whitton, K. E. Lapan, K. K. Brigman et al., LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice, Science, vol.255, issue.5051, pp.1576-1578, 1992.
DOI : 10.1126/science.1347959

E. Muraro, D. Martorelli, E. Turchet, G. Miolo, S. Scalone et al., A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies, Breast Cancer Research, vol.10, issue.6, p.117, 2011.
DOI : 10.1158/1078-0432.CCR-1016-03

E. F. Murta, J. M. De-andrade, R. P. Falcao, and S. Bighetti, Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy, Tumori, vol.86, pp.403-407, 2000.

T. Namekawa, U. G. Wagner, J. J. Goronzy, and C. M. Weyand, Functional subsets of CD4 T cells in rheumatoid synovitis, Arthritis & Rheumatism, vol.40, issue.12, pp.2108-2116, 1998.
DOI : 10.1002/1529-0131(199812)41:12<2108::AID-ART5>3.0.CO;2-Q

J. S. Nielsen, R. A. Sahota, K. Milne, S. E. Kost, N. J. Nesslinger et al., CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27- Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer, Clinical cancer research : an official journal of the American Association for Cancer Research, pp.3281-3292, 2012.
DOI : 10.1158/1078-0432.CCR-12-0234

H. Nishimura, M. Nose, H. Hiai, N. Minato, and T. Honjo, Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor, Immunity, vol.11, issue.2, pp.141-151, 1999.
DOI : 10.1016/S1074-7613(00)80089-8

R. J. North, Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells, Journal of Experimental Medicine, vol.155, issue.4, pp.1063-1074, 1982.
DOI : 10.1084/jem.155.4.1063

M. Numasaki, J. Fukushi, M. Ono, S. K. Narula, P. J. Zavodny et al., Interleukin-17 promotes angiogenesis and tumor growth, Blood, vol.101, issue.7, pp.2620-2627, 2003.
DOI : 10.1182/blood-2002-05-1461

M. Numasaki, M. Watanabe, T. Suzuki, H. Takahashi, A. Nakamura et al., IL-17 Enhances the Net Angiogenic Activity and In Vivo Growth of Human Non-Small Cell Lung Cancer in SCID Mice through Promoting CXCR-2-Dependent Angiogenesis, The Journal of Immunology, vol.175, issue.9, pp.6177-6189, 2005.
DOI : 10.4049/jimmunol.175.9.6177

R. I. Nurieva, Y. Chung, G. J. Martinez, X. O. Yang, S. Tanaka et al., Bcl6 Mediates the Development of T Follicular Helper Cells, Science, vol.325, issue.5943, pp.1001-1005, 2009.
DOI : 10.1126/science.1176676

M. Obeid, ERP57 Membrane Translocation Dictates the Immunogenicity of Tumor Cell Death by Controlling the Membrane Translocation of Calreticulin, The Journal of Immunology, vol.181, issue.4, pp.2533-2543, 2008.
DOI : 10.4049/jimmunol.181.4.2533

M. Obeid, A. Tesniere, F. Ghiringhelli, G. M. Fimia, L. Apetoh et al., Calreticulin exposure dictates the immunogenicity of cancer cell death, Nature Medicine, vol.279, issue.1, pp.54-61, 2007.
DOI : 10.1038/nm1523
URL : https://hal.archives-ouvertes.fr/inserm-00451702

N. Oda, K. Shimazu, Y. Naoi, K. Morimoto, A. Shimomura et al., Intratumoral regulatory T cells as an independent predictive factor for pathological complete response to neoadjuvant paclitaxel followed by 5-FU/epirubicin/cyclophosphamide in breast cancer patients, Breast Cancer Research and Treatment, vol.135, issue.Suppl 5, pp.107-116, 2012.
DOI : 10.1007/s10549-012-2245-8

K. J. Oestreich, S. E. Mohn, and A. S. Weinmann, Molecular mechanisms that control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility with a TFH-like gene profile, Nature Immunology, vol.105, issue.4, pp.405-411, 2012.
DOI : 10.1084/jem.20102065

K. J. Oestreich and A. S. Weinmann, Master regulators or lineage-specifying? Changing views on CD4+ T cell transcription factors, Nature Reviews Immunology, vol.36, issue.11, pp.799-804, 2012.
DOI : 10.1038/nri3321

S. Ogino, J. Galon, C. S. Fuchs, and G. Dranoff, Cancer immunology???analysis of host and tumor factors for personalized medicine, Nature Reviews Clinical Oncology, vol.25, issue.12, pp.711-719, 2011.
DOI : 10.1038/nrclinonc.2011.122

T. Okazaki, Y. Tanaka, R. Nishio, T. Mitsuiye, A. Mizoguchi et al., Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice, Nature Medicine, vol.9, issue.12, pp.1477-1483, 2003.
DOI : 10.1038/nm955

K. Ozaki, R. Spolski, C. G. Feng, C. F. Qi, J. Cheng et al., A Critical Role for IL-21 in Regulating Immunoglobulin Production, Science, vol.298, issue.5598, pp.1630-1634, 2002.
DOI : 10.1126/science.1077002

H. Park, Z. Li, X. O. Yang, S. H. Chang, R. Nurieva et al., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17, Nature Immunology, vol.103, issue.11, pp.1133-1141, 2005.
DOI : 10.1038/35051100

M. J. Pinto-medel, J. A. Garcia-leon, B. Oliver-martos, C. Lopez-gomez, G. Luque et al., The CD4+ T-cell subset lacking expression of the CD28 costimulatory molecule is expanded and shows a higher activation state in multiple sclerosis, Journal of Neuroimmunology, vol.243, issue.1-2, pp.1-11, 2012.
DOI : 10.1016/j.jneuroim.2011.11.008

J. K. Polansky, K. Kretschmer, J. Freyer, S. Floess, A. Garbe et al., DNA methylation controls Foxp3 gene expression, European Journal of Immunology, vol.175, issue.6, pp.1654-1663, 2008.
DOI : 10.1002/eji.200838105

S. A. Quezada, T. R. Simpson, K. S. Peggs, T. Merghoub, J. Vider et al., T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts, The Journal of Experimental Medicine, vol.62, issue.3, pp.637-650, 2010.
DOI : 10.1084/jem.20062056
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839156

H. Rabenstein, A. C. Behrendt, J. W. Ellwart, R. Naumann, M. Horsch et al., Differential Kinetics of Antigen Dependency of CD4+ and CD8+ T Cells, The Journal of Immunology, vol.192, issue.8, pp.3507-3517, 2014.
DOI : 10.4049/jimmunol.1302725

A. U. Rasheed, H. P. Rahn, F. Sallusto, M. Lipp, and G. Muller, Follicular B helper T cell activity is confined to CXCR5hiICOShi CD4 T cells and is independent of CD57 expression, European Journal of Immunology, vol.2, issue.7, pp.1892-1903, 2006.
DOI : 10.1002/eji.200636136

I. Ray-coquard, C. Cropet, M. Van-glabbeke, C. Sebban, L. Cesne et al., Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas, Cancer Research, vol.69, issue.13, pp.5383-5391, 2009.
DOI : 10.1158/0008-5472.CAN-08-3845

B. S. Reis, A. Rogoz, F. A. Costa-pinto, I. Taniuchi, and D. Mucida, Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4+ T cell immunity, Nature Immunology, vol.175, issue.3, pp.271-280, 2013.
DOI : 10.1016/j.immuni.2008.05.010

M. Reuschenbach, M. Doeberitz, and N. Wentzensen, A systematic review of humoral immune responses against tumor antigens. Cancer immunology, immunotherapy : CII 58, pp.1535-1544, 2009.

J. P. Ridge, D. Rosa, F. Matzinger, and P. , A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell, Nature, vol.393, issue.6684, pp.474-478, 1998.
DOI : 10.1038/30989

R. Pinilla, S. M. Roncador, G. Rodriguez-peralto, J. L. Mollejo, M. Garcia et al., Primary Cutaneous CD4+ Small/Medium-sized Pleomorphic T-cell Lymphoma Expresses Follicular T-cell Markers, The American Journal of Surgical Pathology, vol.33, issue.1, pp.81-90, 2009.
DOI : 10.1097/PAS.0b013e31818e52fe

S. Romagnani, E. Maggi, F. Liotta, L. Cosmi, and F. Annunziato, Properties and origin of human Th17 cells, Molecular Immunology, vol.47, issue.1, pp.3-7, 2009.
DOI : 10.1016/j.molimm.2008.12.019

G. Roncador, P. J. Brown, L. Maestre, S. Hue, J. L. Martinez-torrecuadrada et al., Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level, European Journal of Immunology, vol.101, issue.6, pp.1681-1691, 2005.
DOI : 10.1002/eji.200526189

S. A. Rosenberg, B. S. Packard, P. M. Aebersold, D. Solomon, S. L. Topalian et al., Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report, pp.1676-1680, 1988.

S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda, Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25), 1995.

F. Sallusto, J. Geginat, and A. Lanzavecchia, : Function, Generation, and Maintenance, Annual Review of Immunology, vol.22, issue.1, pp.745-763, 2004.
DOI : 10.1146/annurev.immunol.22.012703.104702

R. Samaritani, G. Corrado, E. Vizza, and C. Sbiroli, Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer, BMC Cancer, vol.2, issue.11, p.65, 2007.
DOI : 10.1038/ncponc0342

B. Santner-nanan, N. Seddiki, E. Zhu, V. Quent, A. Kelleher et al., Accelerated age-dependent transition of human regulatory T cells to effector memory phenotype, International Immunology, vol.20, issue.3, pp.375-383, 2008.
DOI : 10.1093/intimm/dxm151

P. Schaerli, K. Willimann, A. B. Lang, M. Lipp, P. Loetscher et al., Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function, The Journal of Experimental Medicine, vol.162, issue.11, pp.1553-1562, 2000.
DOI : 10.4049/jimmunol.164.4.1653

F. A. Scheeren, M. Naspetti, S. Diehl, R. Schotte, M. Nagasawa et al., STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression, Nature immunology, vol.25, issue.3, pp.303-313, 2005.
DOI : 10.1046/j.1365-2141.1999.01233.x

M. Schmidt, D. Bohm, C. Von-torne, E. Steiner, A. Puhl et al., The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer, Cancer Research, vol.68, issue.13, pp.5405-5413, 2008.
DOI : 10.1158/0008-5472.CAN-07-5206

S. Schreck, D. Friebel, M. Buettner, L. Distel, G. Grabenbauer et al., Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma, Hematological Oncology, vol.82, issue.3, pp.31-39, 2009.
DOI : 10.1002/hon.878

E. S. Schultz, B. Lethe, C. L. Cambiaso, J. Van-snick, P. Chaux et al., A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes, Cancer research, vol.60, pp.6272-6275, 2000.

N. Seddiki, B. Santner-nanan, J. Martinson, J. Zaunders, S. Sasson et al., Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells, The Journal of Experimental Medicine, vol.66, issue.7, pp.1693-1700, 2006.
DOI : 10.1002/eji.200425763

S. Seresini, M. Origoni, F. Lillo, L. Caputo, A. M. Paganoni et al., IFN-?? Produced by Human Papilloma Virus-18 E6-Specific CD4+ T Cells Predicts the Clinical Outcome after Surgery in Patients with High-Grade Cervical Lesions, The Journal of Immunology, vol.179, issue.10, pp.7176-7183, 2007.
DOI : 10.4049/jimmunol.179.10.7176

V. Shankaran, H. Ikeda, A. T. Bruce, J. M. White, P. E. Swanson et al., IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity, Nature, vol.410, issue.6832, pp.1107-1111, 2001.
DOI : 10.1038/35074122

S. Shimato, L. M. Maier, R. Maier, J. N. Bruce, R. C. Anderson et al., Profound tumor-specific Th2 bias in patients with malignant glioma, BMC Cancer, vol.104, issue.3, p.561, 2012.
DOI : 10.1002/ijc.10964

G. L. Sica, I. H. Choi, G. Zhu, K. Tamada, S. D. Wang et al., B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell Immunity, Immunity, vol.18, issue.6, pp.849-861, 2003.
DOI : 10.1016/S1074-7613(03)00152-3

E. H. Slager, M. Borghi, C. E. Van-der-minne, C. A. Aarnoudse, M. J. Havenga et al., CD4+ Th2 Cell Recognition of HLA-DR-Restricted Epitopes Derived from CAMEL: A Tumor Antigen Translated in an Alternative Open Reading Frame, The Journal of Immunology, vol.170, issue.3, pp.1490-1497, 2003.
DOI : 10.4049/jimmunol.170.3.1490

Y. Sota, Y. Naoi, R. Tsunashima, N. Kagara, K. Shimazu et al., Construction of novel immune-related signature for prediction of pathological complete response to neoadjuvant chemotherapy in human breast cancer, Annals of Oncology, vol.25, issue.1, pp.100-106, 2014.
DOI : 10.1093/annonc/mdt427

G. Stoll, D. Enot, B. Mlecnik, J. Galon, L. Zitvogel et al., Immunerelated gene signatures predict the outcome of neoadjuvant chemotherapy, 2014.

M. Strioga, V. Pasukoniene, C. , and D. , CD8+???CD28??? and CD8+???CD57+ T cells and their role in health and disease, Immunology, vol.6, issue.1, pp.17-32, 2011.
DOI : 10.1111/j.1365-2567.2011.03470.x

D. Sugiyama, H. Nishikawa, Y. Maeda, M. Nishioka, A. Tanemura et al., Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans, Proceedings of the National Academy of Sciences of the United States of America, pp.17945-17950, 2013.
DOI : 10.1073/pnas.1316796110

J. C. Sun and M. J. Bevan, Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help, Science, vol.300, issue.5617, pp.339-342, 2003.
DOI : 10.1126/science.1083317

Q. Sun, R. L. Burton, L. , and K. G. , Cytokine production and cytolytic mechanism of CD4+ cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures, Blood, vol.99, issue.9, pp.3302-3309, 2002.
DOI : 10.1182/blood.V99.9.3302

M. Tabachnyk, L. V. Distel, M. Buttner, G. G. Grabenbauer, E. Nkenke et al., Radiochemotherapy induces a favourable tumour infiltrating inflammatory cell profile in head and neck cancer, Oral Oncology, vol.48, issue.7, pp.594-601, 2012.
DOI : 10.1016/j.oraloncology.2012.01.024

Q. Tang, K. J. Henriksen, E. K. Boden, A. J. Tooley, J. Ye et al., Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells, The Journal of Immunology, vol.171, issue.7, pp.3348-3352, 2003.
DOI : 10.4049/jimmunol.171.7.3348

E. Tartour, F. Fossiez, I. Joyeux, A. Galinha, A. Gey et al., Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice, Cancer research, vol.59, pp.3698-3704, 1999.

E. Tassi, F. Gavazzi, L. Albarello, V. Senyukov, R. Longhi et al., Carcinoembryonic Antigen-Specific but Not Antiviral CD4+ T Cell Immunity Is Impaired in Pancreatic Carcinoma Patients, The Journal of Immunology, vol.181, issue.9, pp.6595-6603, 2008.
DOI : 10.4049/jimmunol.181.9.6595

A. Tesniere, F. Schlemmer, V. Boige, O. Kepp, I. Martins et al., Immunogenic death of colon cancer cells treated with oxaliplatin, Oncogene, vol.177, issue.4, pp.482-491, 2010.
DOI : 10.1172/JCI35180

M. B. Teunissen, C. W. Koomen, R. De-waal-malefyt, E. A. Wierenga, and J. D. Bos, Interleukin-17 and Interferon-?? Synergize in the Enhancement of Proinflammatory Cytokine Production by Human Keratinocytes, Journal of Investigative Dermatology, vol.111, issue.4, pp.645-649, 1998.
DOI : 10.1046/j.1523-1747.1998.00347.x

A. M. Thornton, P. E. Korty, D. Q. Tran, E. A. Wohlfert, P. E. Murray et al., Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells, The Journal of Immunology, vol.184, issue.7, pp.3433-3441, 2010.
DOI : 10.4049/jimmunol.0904028

S. L. Topalian, F. S. Hodi, J. R. Brahmer, S. N. Gettinger, D. C. Smith et al., Safety, Activity, and Immune Correlates of Anti???PD-1 Antibody in Cancer, New England Journal of Medicine, vol.366, issue.26, pp.2443-2454, 2012.
DOI : 10.1056/NEJMoa1200690

S. L. Topalian, L. Rivoltini, M. Mancini, N. R. Markus, P. F. Robbins et al., Human CD4+ T cells specifically recognize a shared melanomaassociated antigen encoded by the tyrosinase gene, Proceedings of the National Academy of Sciences of the United States of America 91, pp.9461-9465, 1994.

M. Tosolini, A. Kirilovsky, B. Mlecnik, T. Fredriksen, S. Mauger et al., Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer, Cancer Research, vol.71, issue.4, pp.1263-1271, 2011.
DOI : 10.1158/0008-5472.CAN-10-2907

J. S. Tzartos, M. A. Friese, M. J. Craner, J. Palace, J. Newcombe et al., Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis, The American Journal of Pathology, vol.172, issue.1, pp.146-155, 2008.
DOI : 10.2353/ajpath.2008.070690

E. Vacchelli, L. Galluzzi, W. H. Fridman, J. Galon, C. Sautes-fridman et al., Trial watch: Chemotherapy with immunogenic cell death inducers, pp.179-188, 2012.

E. Vacchelli, L. Galluzzi, V. Rousseau, A. Rigoni, A. Tesniere et al., Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer, pp.271-278, 2012.

C. M. Vajdic, S. P. Mcdonald, M. R. Mccredie, M. T. Van-leeuwen, J. H. Stewart et al., Cancer Incidence Before and After Kidney Transplantation, JAMA, vol.296, issue.23, pp.2823-2831, 2006.
DOI : 10.1001/jama.296.23.2823

D. Valmori, A. Merlo, N. E. Souleimanian, C. S. Hesdorffer, and M. Ayyoub, A peripheral circulating compartment of natural naive CD4+ Tregs, Journal of Clinical Investigation, vol.115, issue.7, pp.1953-1962, 2005.
DOI : 10.1172/JCI23963

D. Valmori, C. Raffin, I. Raimbaud, and M. Ayyoub, Human RORgammat+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors, Proceedings of the National Academy of Sciences of the United States of America, pp.19402-19407, 2010.

S. Viaud, C. Flament, M. Zoubir, P. Pautier, A. Lecesne et al., Cyclophosphamide Induces Differentiation of Th17 Cells in Cancer Patients, Cancer Research, vol.71, issue.3, pp.661-665, 2011.
DOI : 10.1158/0008-5472.CAN-10-1259

N. Vigneron, V. Stroobant, B. J. Van-den-eynde, and P. Van-der-bruggen, Database of T cell-defined human tumor antigens: the 2013 update, Cancer Immun, vol.13, p.15, 2013.

J. Vincent, G. Mignot, F. Chalmin, S. Ladoire, M. Bruchard et al., 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity, Cancer Research, vol.70, issue.8, pp.3052-3061, 2010.
DOI : 10.1158/0008-5472.CAN-09-3690

E. Volpe, M. Touzot, N. Servant, M. A. Marloie-provost, P. Hupe et al., Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production, Blood, vol.114, issue.17, pp.3610-3614, 2009.
DOI : 10.1182/blood-2009-05-223768

C. Wang, P. Hillsamer, K. , and C. H. , Phenotype, effector function, and tissue localization of PD-1-expressing human follicular helper T cell subsets, BMC Immunology, vol.12, issue.1, p.53, 2011.
DOI : 10.1172/JCI11902

J. Wang, A. Ioan-facsinay, E. I. Van-der-voort, T. W. Huizinga, and R. E. Toes, Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells, European Journal of Immunology, vol.115, issue.1, pp.129-138, 2007.
DOI : 10.1002/eji.200636435

J. Wang, T. Yoshida, F. Nakaki, H. Hiai, T. Okazaki et al., Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes, Proceedings of the National Academy of Sciences, vol.102, issue.33, pp.11823-11828, 2005.
DOI : 10.1073/pnas.0505497102

L. Wang, T. Yi, M. Kortylewski, D. M. Pardoll, D. Zeng et al., IL-17 can promote tumor growth through an IL-6???Stat3 signaling pathway, The Journal of Experimental Medicine, vol.206, issue.7, pp.1457-1464, 2009.
DOI : 10.1016/j.jhep.2008.12.033

E. J. Wherry, S. J. Ha, S. M. Kaech, W. N. Haining, S. Sarkar et al., Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection, Immunity, vol.27, issue.4, pp.670-684, 2007.
DOI : 10.1016/j.immuni.2007.09.006

N. J. Wilson, K. Boniface, J. R. Chan, B. S. Mckenzie, W. M. Blumenschein et al., Development, cytokine profile and function of human interleukin 17???producing helper T cells, Nature Immunology, vol.176, issue.9, pp.950-957, 2007.
DOI : 10.1084/jem.194.4.519

D. Wu, P. Wu, Q. Huang, Y. Liu, J. Ye et al., Interleukin-17: A Promoter in Colorectal Cancer Progression, Clinical and Developmental Immunology, vol.26, issue.6, p.436307, 2013.
DOI : 10.4049/jimmunol.1003251

Y. Xie, A. Akpinarli, C. Maris, E. L. Hipkiss, M. Lane et al., T cells differentiated in vivo eradicate established melanoma, The Journal of Experimental Medicine, vol.146, issue.3, pp.651-667, 2010.
DOI : 10.1038/nm1312

R. Yamaguchi, M. Tanaka, A. Yano, G. M. Tse, M. Yamaguchi et al., Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer, Human Pathology, vol.43, issue.10, pp.1688-1694, 2012.
DOI : 10.1016/j.humpath.2011.12.013

S. Yang and F. G. Haluska, Treatment of Melanoma with 5-Fluorouracil or Dacarbazine In Vitro Sensitizes Cells to Antigen-Specific CTL Lysis through Perforin/Granzyme- and Fas-Mediated Pathways, The Journal of Immunology, vol.172, issue.7, pp.4599-4608, 2004.
DOI : 10.4049/jimmunol.172.7.4599

Z. J. Ye, Q. Zhou, Y. Y. Gu, S. M. Qin, W. L. Ma et al., Generation and Differentiation of IL-17-Producing CD4+ T Cells in Malignant Pleural Effusion, The Journal of Immunology, vol.185, issue.10, pp.6348-6354, 2010.
DOI : 10.4049/jimmunol.1001728

M. J. Yellin, K. Sippel, G. Inghirami, L. R. Covey, J. J. Lee et al., CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function, Journal of immunology, vol.152, pp.598-608, 1994.

T. Yi, X. Li, S. Yao, L. Wang, Y. Chen et al., Host APCs Augment In Vivo Expansion of Donor Natural Regulatory T Cells via B7H1/B7.1 in Allogeneic Recipients, The Journal of Immunology, vol.186, issue.5, pp.2739-2749, 2011.
DOI : 10.4049/jimmunol.1002939

N. K. Yoon, E. L. Maresh, D. Shen, Y. Elshimali, S. Apple et al., Higher levels of GATA3 predict better survival in women with breast cancer, Human Pathology, vol.41, issue.12, pp.1794-1801, 2010.
DOI : 10.1016/j.humpath.2010.06.010

D. Yu, S. Rao, L. M. Tsai, S. K. Lee, Y. He et al., The Transcriptional Repressor Bcl-6 Directs T Follicular Helper Cell Lineage Commitment, Immunity, vol.31, issue.3, pp.457-468, 2009.
DOI : 10.1016/j.immuni.2009.07.002

I. Yusuf, R. Kageyama, L. Monticelli, R. J. Johnston, D. Ditoro et al., Germinal Center T Follicular Helper Cell IL-4 Production Is Dependent on Signaling Lymphocytic Activation Molecule Receptor (CD150), The Journal of Immunology, vol.185, issue.1, pp.190-202, 2010.
DOI : 10.4049/jimmunol.0903505

A. J. Zajac, J. N. Blattman, K. Murali-krishna, D. J. Sourdive, M. Suresh et al., Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function, The Journal of Experimental Medicine, vol.393, issue.12, pp.2205-2213, 1998.
DOI : 10.1038/373123a0

J. P. Zhang, J. Yan, J. Xu, X. H. Pang, M. S. Chen et al., Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients, Journal of Hepatology, vol.50, issue.5, pp.980-989, 2009.
DOI : 10.1016/j.jhep.2008.12.033

L. Zhang, K. Dermawan, M. Jin, R. Liu, H. Zheng et al., Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy, Clinical Immunology, vol.129, issue.2, pp.219-229, 2008.
DOI : 10.1016/j.clim.2008.07.013

R. Zhang, A. Huynh, G. Whitcher, J. Chang, J. S. Maltzman et al., An obligate cell-intrinsic function for CD28 in Tregs, Journal of Clinical Investigation, vol.123, pp.580-593, 2013.
DOI : 10.1172/JCI65013DS1

C. C. Zielinski, I. Stuller, F. Dorner, P. Potzi, C. Muller et al., Impaired primary, but not secondary, immune response in breast cancer patients under adjuvant chemotherapy, Cancer, vol.2, issue.8, pp.1648-1652, 1986.
DOI : 10.1002/1097-0142(19861015)58:8<1648::AID-CNCR2820580812>3.0.CO;2-E

E. Zorn, H. , and T. , A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation, European Journal of Immunology, vol.287, issue.2, pp.592-601, 1999.
DOI : 10.1002/(SICI)1521-4141(199902)29:02<592::AID-IMMU592>3.0.CO;2-2

W. Zou, C. , and L. , Inhibitory B7-family molecules in the tumour microenvironment, Nature Reviews Immunology, vol.106, issue.6, pp.467-477, 2008.
DOI : 10.1038/nri2326

W. Zou, R. , and N. P. , TH17 cells in tumour immunity and immunotherapy, Nature Reviews Immunology, vol.8, issue.4, pp.248-256, 2010.
DOI : 10.1038/nri2742